Lin, Zhi-Jian <br/><br/>
Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction.  [electronic resource] 

 -  Bioscience reports  02 2018 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-4935 
<br/><br/><label>Standard No.: </label>10.1042/BSR20170730  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aspirin--administration & dosage<br/>Cerebral Infarction--blood<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Drug Combinations<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Tissue Plasminogen Activator--administration & dosage<br/>Triglycerides--blood